chr2-227379189-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024795.4(TM4SF20):​c.80C>T​(p.Ala27Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 1,613,730 control chromosomes in the GnomAD database, including 13,573 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A27A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.11 ( 1045 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12528 hom. )

Consequence

TM4SF20
NM_024795.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.102

Publications

27 publications found
Variant links:
Genes affected
TM4SF20 (HGNC:26230): (transmembrane 4 L six family member 20) The protein encoded by this gene is a member of the four-transmembrane L6 superfamily. Members of this family function in various cellular processes including cell proliferation, motility, and adhesion via their interactions with integrins. In human brain tissue, this gene is expressed at high levels in the parietal lobe, occipital lobe, hippocampus, pons, white matter, corpus callosum, and cerebellum. Knockout of the homologous gene in mouse results in a neurobehavioral phenotype with suggested enhanced motor coordination. A deletion mutation in the human gene is associated with specific language impairment-5. [provided by RefSeq, Jul 2016]
TM4SF20 Gene-Disease associations (from GenCC):
  • specific language impairment 5
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022626221).
BP6
Variant 2-227379189-G-A is Benign according to our data. Variant chr2-227379189-G-A is described in ClinVar as Benign. ClinVar VariationId is 1166272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TM4SF20NM_024795.4 linkc.80C>T p.Ala27Val missense_variant Exon 1 of 4 ENST00000304568.4 NP_079071.2 Q53R12
TM4SF20XM_011511876.3 linkc.-205+2400C>T intron_variant Intron 1 of 4 XP_011510178.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TM4SF20ENST00000304568.4 linkc.80C>T p.Ala27Val missense_variant Exon 1 of 4 1 NM_024795.4 ENSP00000303028.3 Q53R12
TM4SF20ENST00000449706.1 linkc.*37C>T downstream_gene_variant 4 ENSP00000416565.1 C9JES4

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16249
AN:
152000
Hom.:
1046
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0238
Gnomad AMI
AF:
0.285
Gnomad AMR
AF:
0.0964
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.190
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.141
Gnomad OTH
AF:
0.128
GnomAD2 exomes
AF:
0.122
AC:
30744
AN:
251312
AF XY:
0.125
show subpopulations
Gnomad AFR exome
AF:
0.0230
Gnomad AMR exome
AF:
0.0729
Gnomad ASJ exome
AF:
0.150
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.158
Gnomad NFE exome
AF:
0.139
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.130
AC:
189304
AN:
1461612
Hom.:
12528
Cov.:
32
AF XY:
0.130
AC XY:
94218
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.0209
AC:
698
AN:
33476
American (AMR)
AF:
0.0737
AC:
3295
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.144
AC:
3766
AN:
26136
East Asian (EAS)
AF:
0.179
AC:
7099
AN:
39698
South Asian (SAS)
AF:
0.0911
AC:
7855
AN:
86242
European-Finnish (FIN)
AF:
0.157
AC:
8381
AN:
53364
Middle Eastern (MID)
AF:
0.142
AC:
820
AN:
5762
European-Non Finnish (NFE)
AF:
0.135
AC:
149668
AN:
1111828
Other (OTH)
AF:
0.128
AC:
7722
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
5442
10884
16327
21769
27211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5190
10380
15570
20760
25950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16251
AN:
152118
Hom.:
1045
Cov.:
33
AF XY:
0.107
AC XY:
7989
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0237
AC:
986
AN:
41528
American (AMR)
AF:
0.0965
AC:
1476
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
552
AN:
3472
East Asian (EAS)
AF:
0.191
AC:
987
AN:
5168
South Asian (SAS)
AF:
0.100
AC:
484
AN:
4822
European-Finnish (FIN)
AF:
0.156
AC:
1642
AN:
10554
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.141
AC:
9555
AN:
67968
Other (OTH)
AF:
0.128
AC:
270
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.571
Heterozygous variant carriers
0
461
922
1384
1845
2306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
4159
Bravo
AF:
0.0998
TwinsUK
AF:
0.133
AC:
492
ALSPAC
AF:
0.124
AC:
479
ESP6500AA
AF:
0.0261
AC:
115
ESP6500EA
AF:
0.141
AC:
1209
ExAC
AF:
0.122
AC:
14819
Asia WGS
AF:
0.142
AC:
491
AN:
3478
EpiCase
AF:
0.150
EpiControl
AF:
0.146

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

TM4SF20-related disorder Benign:1
Oct 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
2.4
DANN
Benign
0.073
DEOGEN2
Benign
0.0028
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.10
PrimateAI
Benign
0.30
T
PROVEAN
Benign
1.5
N
REVEL
Benign
0.076
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.96
D
Vest4
0.030
MPC
0.011
ClinPred
0.016
T
GERP RS
1.8
PromoterAI
-0.023
Neutral
Varity_R
0.022
gMVP
0.25
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7574414; hg19: chr2-228243905; COSMIC: COSV58818572; COSMIC: COSV58818572; API